Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Change in Acquisitions & Divestments: 2023-2024

Historic Change in Acquisitions & Divestments for Oncology Institute (TOI) over the last 2 years, with FY2024 value amounting to $50.0 million.

  • Oncology Institute's Change in Acquisitions & Divestments rose 1661.81% to $10.0 million in Q3 2024 from the same period last year, while for Mar 2025 it was $30.0 million, marking a year-over-year decrease of 5789.61%. This contributed to the annual value of $50.0 million for FY2024, which is 3846.76% down from last year.
  • As of FY2024, Oncology Institute's Change in Acquisitions & Divestments stood at $50.0 million, which was down 3846.76% from $81.3 million recorded in FY2023.
  • In the past 5 years, Oncology Institute's Change in Acquisitions & Divestments registered a high of $81.3 million during FY2023, and its lowest value of $50.0 million during FY2024.